After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Immunocore Holdings plc ADR is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Immunocore Holdings plc ADR is $1.65B. A total of 0.46 million shares were traded on the day, compared to an average of 305.58K shares.
In the most recent transaction, Berman David M sold 31,341 shares of IMCR for 40.26 per share on Dec 04 ’25. After the transaction, the HEAD OF R&D now owns 0 company shares. In a previous transaction on Dec 05 ’25, Berman David M sold 572 shares at 40.14 per share. IMCR shares that HEAD OF R&D owns now total 0.
Among the insiders who sold shares, Berman David M disposed of 69,404 shares on Nov 26 ’25 at a per-share price of $40.12. This resulted in the HEAD OF R&D holding 0 shares of IMCR after the transaction. In another insider transaction, Berman David M sold 5,521 shares at $40.09 per share on Nov 28 ’25. Company shares held by the HEAD OF R&D now total 0.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, IMCR has a high of $40.71 and a low of $23.15.
As of this writing, IMCR has an earnings estimate of -$0.19 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of $0.0 per share and a lower estimate of -$0.39. The company reported an EPS of -$0.47 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. IMCR’s latest balance sheet shows that the firm has $321.06M in Cash & Short Term Investments as of fiscal 2021. There were $86.16M in debt and $82.57M in liabilities at the time. Its Book Value Per Share was $7.81, while its Total Shareholder’s Equity was $231.53M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IMCR is Buy with a score of 4.24.
